List of Tables
Table 1. COVID-19 In-Vitro Diagnostics Market Trends
Table 2. COVID-19 In-Vitro Diagnostics Market Drivers & Opportunity
Table 3. COVID-19 In-Vitro Diagnostics Market Challenges
Table 4. COVID-19 In-Vitro Diagnostics Market Restraints
Table 5. Global COVID-19 In-Vitro Diagnostics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies COVID-19 In-Vitro Diagnostics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies COVID-19 In-Vitro Diagnostics Product Type
Table 9. Key Companies Time to Begin Mass Production of COVID-19 In-Vitro Diagnostics
Table 10. Global COVID-19 In-Vitro Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 In-Vitro Diagnostics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global COVID-19 In-Vitro Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global COVID-19 In-Vitro Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global COVID-19 In-Vitro Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global COVID-19 In-Vitro Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global COVID-19 In-Vitro Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global COVID-19 In-Vitro Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global COVID-19 In-Vitro Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global COVID-19 In-Vitro Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global COVID-19 In-Vitro Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global COVID-19 In-Vitro Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global COVID-19 In-Vitro Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global COVID-19 In-Vitro Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global COVID-19 In-Vitro Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global COVID-19 In-Vitro Diagnostics Sales Value by Region (2019-2024) & (%)
Table 27. Global COVID-19 In-Vitro Diagnostics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions COVID-19 In-Vitro Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions COVID-19 In-Vitro Diagnostics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions COVID-19 In-Vitro Diagnostics Sales Value, (2025-2030) & (US$ Million)
Table 31. Cellex Basic Information List
Table 32. Cellex Description and Business Overview
Table 33. Cellex COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 34. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Cellex (2019-2024)
Table 35. Cellex Recent Developments
Table 36. Abbott Basic Information List
Table 37. Abbott Description and Business Overview
Table 38. Abbott COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 39. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Abbott (2019-2024)
Table 40. Abbott Recent Developments
Table 41. Roche Basic Information List
Table 42. Roche Description and Business Overview
Table 43. Roche COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 44. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Roche (2019-2024)
Table 45. Roche Recent Developments
Table 46. BioMedomics Basic Information List
Table 47. BioMedomics Description and Business Overview
Table 48. BioMedomics COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 49. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of BioMedomics (2019-2024)
Table 50. BioMedomics Recent Developments
Table 51. BD Basic Information List
Table 52. BD Description and Business Overview
Table 53. BD COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 54. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of BD (2019-2024)
Table 55. BD Recent Developments
Table 56. Henry Schein Basic Information List
Table 57. Henry Schein Description and Business Overview
Table 58. Henry Schein COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 59. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Henry Schein (2019-2024)
Table 60. Henry Schein Recent Developments
Table 61. Safecare Bio-Tech Basic Information List
Table 62. Safecare Bio-Tech Description and Business Overview
Table 63. Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 64. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Safecare Bio-Tech (2019-2024)
Table 65. Safecare Bio-Tech Recent Developments
Table 66. Mayo Clinic Laboratories Basic Information List
Table 67. Mayo Clinic Laboratories Description and Business Overview
Table 68. Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 69. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Mayo Clinic Laboratories (2019-2024)
Table 70. Mayo Clinic Laboratories Recent Developments
Table 71. Chembio Diagnostics Basic Information List
Table 72. Chembio Diagnostics Description and Business Overview
Table 73. Chembio Diagnostics COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 74. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Chembio Diagnostics (2019-2024)
Table 75. Chembio Diagnostics Recent Developments
Table 76. Mount Sinai Laboratory Basic Information List
Table 77. Mount Sinai Laboratory Description and Business Overview
Table 78. Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 79. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Mount Sinai Laboratory (2019-2024)
Table 80. Mount Sinai Laboratory Recent Developments
Table 81. Ortho Clinical Diagnostics Basic Information List
Table 82. Ortho Clinical Diagnostics Description and Business Overview
Table 83. Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 84. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Ortho Clinical Diagnostics (2019-2024)
Table 85. Ortho Clinical Diagnostics Recent Developments
Table 86. Zhejiang Orient Gene Biotech Basic Information List
Table 87. Zhejiang Orient Gene Biotech Description and Business Overview
Table 88. Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 89. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Zhejiang Orient Gene Biotech (2019-2024)
Table 90. Zhejiang Orient Gene Biotech Recent Developments
Table 91. Innovita Biological Technology Basic Information List
Table 92. Innovita Biological Technology Description and Business Overview
Table 93. Innovita Biological Technology COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 94. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Innovita Biological Technology (2019-2024)
Table 95. Innovita Biological Technology Recent Developments
Table 96. Guangzhou Wondfo Biotech Basic Information List
Table 97. Guangzhou Wondfo Biotech Description and Business Overview
Table 98. Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 99. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Guangzhou Wondfo Biotech (2019-2024)
Table 100. Guangzhou Wondfo Biotech Recent Developments
Table 101. Guangdong Hecin-Scientific Basic Information List
Table 102. Guangdong Hecin-Scientific Description and Business Overview
Table 103. Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 104. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Guangdong Hecin-Scientific (2019-2024)
Table 105. Guangdong Hecin-Scientific Recent Developments
Table 106. Dynamiker Biotechnology (Tianjin) Basic Information List
Table 107. Dynamiker Biotechnology (Tianjin) Description and Business Overview
Table 108. Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 109. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of Dynamiker Biotechnology (Tianjin) (2019-2024)
Table 110. Dynamiker Biotechnology (Tianjin) Recent Developments
Table 111. ADVAITE Basic Information List
Table 112. ADVAITE Description and Business Overview
Table 113. ADVAITE COVID-19 In-Vitro Diagnostics Products, Services and Solutions
Table 114. Revenue (US$ Million) in COVID-19 In-Vitro Diagnostics Business of ADVAITE (2019-2024)
Table 115. ADVAITE Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. COVID-19 In-Vitro Diagnostics Downstream Customers
Table 119. COVID-19 In-Vitro Diagnostics Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. COVID-19 In-Vitro Diagnostics Product Picture
Figure 2. Global COVID-19 In-Vitro Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global COVID-19 In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 4. COVID-19 In-Vitro Diagnostics Report Years Considered
Figure 5. Global COVID-19 In-Vitro Diagnostics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by COVID-19 In-Vitro Diagnostics Revenue in 2023
Figure 7. COVID-19 In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Rapid Diagnostic Test (RDT) Picture
Figure 9. Enzyme Linked Immunosorbent Assay (ELISA) Picture
Figure 10. Neutralization Assay Picture
Figure 11. Global COVID-19 In-Vitro Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global COVID-19 In-Vitro Diagnostics Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Home
Figure 14. Product Picture of Hospital
Figure 15. Product Picture of Clinical
Figure 16. Global COVID-19 In-Vitro Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global COVID-19 In-Vitro Diagnostics Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America COVID-19 In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 19. North America COVID-19 In-Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe COVID-19 In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe COVID-19 In-Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific COVID-19 In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific COVID-19 In-Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 24. South America COVID-19 In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 25. South America COVID-19 In-Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa COVID-19 In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa COVID-19 In-Vitro Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions COVID-19 In-Vitro Diagnostics Sales Value (%), (2019-2030)
Figure 29. United States COVID-19 In-Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 31. United States COVID-19 In-Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe COVID-19 In-Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe COVID-19 In-Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 35. China COVID-19 In-Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 36. China COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 37. China COVID-19 In-Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan COVID-19 In-Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan COVID-19 In-Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea COVID-19 In-Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea COVID-19 In-Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia COVID-19 In-Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia COVID-19 In-Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 47. India COVID-19 In-Vitro Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 48. India COVID-19 In-Vitro Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 49. India COVID-19 In-Vitro Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 50. COVID-19 In-Vitro Diagnostics Industrial Chain
Figure 51. COVID-19 In-Vitro Diagnostics Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
